Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.
Study Details
Study Description
Brief Summary
The purpose of this study is to determine the safety and effectiveness of combination therapy with Proleukin and Rituxan on patients with intermediate-and high- grade Non-Hodgkin's lymphoma.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 2 |
Study Design
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Inclusion:
- Diagnosis: CD20+ B-cell non-Hodgkin's lymphoma (NHL) classified as intermediate- or high-grade according to the Working Formulation, subtypes D to H. Must have measureable progressive or refractory disease after no more than three prior chemotherapy regimens.
Exclusion:
-
Clinically significant cardiac dysfunction, or a history of myocardial infarction or heart failure within 6 months of first study treatment
-
Clinically significant pulmonary dysfunction.
-
Liver disease (note hepatitis C seropositive subjects may be enrolled if they have no active disease as demonstrated by undetectable HCV viral loads, biopsy showing no active disease, and/or history of normal transaminases on at least three different dates within one year of first study treatment).
-
Symptomatic thyroid disease requiring medical intervention other than replacement treatment for hypothyroidism.
-
History of autoimmune disease.
-
History of positive serology for human immunodeficiency virus (HIV).
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | ACRC/Arizona Clinical Research Center, Inc. | Tucson | Arizona | United States | 85712 |
2 | Hoag Cancer Center | Newport Beach | California | United States | 92658 |
3 | UC Davis Cancer Center | Sacramento | California | United States | 95817 |
4 | John Wayne Cancer Institute | Santa Monica | California | United States | 90404 |
5 | Stanford University Medical Center | Stanford | California | United States | 94305-5151 |
6 | California Cancer Medical Center | West Covina | California | United States | 91790 |
7 | Georgetown University Medical Center, Lombardi Cancer Center | Washington | District of Columbia | United States | 20007 |
8 | Washington Cancer Institute | Washington | District of Columbia | United States | 20010 |
9 | Division of Hematology/Oncology, University of Miami School of Medicine | Miami | Florida | United States | 333136 |
10 | Northwestern University, Feinberg School of Medicine | Chicago | Illinois | United States | 60611 |
11 | Rush Cancer Institute | Chicago | Illinois | United States | 60612 |
12 | Oncology Specialists, S.C. | Park Ridge | Illinois | United States | 60068 |
13 | Cancer Care Center | Bloomington | Indiana | United States | 47403 |
14 | Consultants in Blood Disorders and Cancer | Louisville | Kentucky | United States | 40207 |
15 | Louisiana Health Sciences Center, Department of Medicine, Hematology/Oncology | Shreveport | Louisiana | United States | 71130 |
16 | Kansas City Oncology and Hematology Group | Kansas City | Missouri | United States | 64111 |
17 | Arch Medical Group, LLC | St. Louis | Missouri | United States | 63141 |
18 | Dartmouth-Hitchcock-Medical Center | Lebanon | New Hampshire | United States | 03756 |
19 | Our Lady of Mercy Medical Center, Comprehensive Cancer Center | Bronx | New York | United States | 10466 |
20 | Memorial Sloan Kettering Cancer Center | New York | New York | United States | 10021 |
21 | East Carolina University School of Medicine/ Division of Hematology/Oncology | Greenville | North Carolina | United States | 27858 |
22 | Roger Maris Health System | Fargo | North Dakota | United States | 58122 |
23 | Gabrail Cancer Center | Canton | Ohio | United States | 44718 |
24 | Oncology Hematology Care Inc. | Cincinnati | Ohio | United States | 45242 |
25 | The Cleveland Clinic Foundation | Cleveland | Ohio | United States | 44195 |
26 | Hematology /Oncology Consultants Inc. | Columbus | Ohio | United States | 43235 |
27 | Oregon Heath and Science University | Portland | Oregon | United States | 97201 |
28 | University of Pennsylvania | Philadelphia | Pennsylvania | United States | 19104 |
29 | Cancer Centers of the Carolinas | Greenville | South Carolina | United States | 29615 |
30 | Germantown Cancer Center | Germantown | Tennessee | United States | 38138 |
31 | Vanderbilt University Medical Center | Nashville | Tennessee | United States | 37232 |
32 | Cancer Specialists of South Texas, P.A. | Corpus Christi | Texas | United States | 78412 |
33 | Virginia Cancer Institute | Richmond | Virginia | United States | 23230 |
Sponsors and Collaborators
- Chiron Corporation
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- IL2NHL05